Ivan Astralaga
Corporate Officer/Principal bij C-RAD AB
Vermogen: 81 061 $ op 31-03-2024
Profiel
Ivan Astralaga is currently the President-Americas at C-RAD AB since 2021.
Prior to this, he worked as the Vice President-Business Development & Sales at Mevion Medical Systems, Inc. from 2019 to 2021.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
C-RAD AB CLASS B
0.06% | 13-06-2023 | 20 204 ( 0.06% ) | 81 061 $ | 31-03-2024 |
Actieve functies van Ivan Astralaga
Bedrijven | Functie | Begin |
---|---|---|
C-RAD AB | Corporate Officer/Principal | 21-05-2021 |
Eerdere bekende functies van Ivan Astralaga
Bedrijven | Functie | Einde |
---|---|---|
Mevion Medical Systems, Inc.
Mevion Medical Systems, Inc. Medical SpecialtiesHealth Technology Mevion Medical Systems, Inc. provides proton therapy systems for cancer centers, clinicians and patients worldwide. Its MEVION S250 Series is designed to deliver proton therapy treatments, optimizing both the outcomes and the economics of proton therapy. Its products include Mevion S250i with hyperscan and Mevion 250mx. The company was founded by Kenneth A. Gall in 2004 and is headquartered in Littleton, MA. | Sales & Marketing | 01-04-2021 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
C-RAD AB | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Mevion Medical Systems, Inc.
Mevion Medical Systems, Inc. Medical SpecialtiesHealth Technology Mevion Medical Systems, Inc. provides proton therapy systems for cancer centers, clinicians and patients worldwide. Its MEVION S250 Series is designed to deliver proton therapy treatments, optimizing both the outcomes and the economics of proton therapy. Its products include Mevion S250i with hyperscan and Mevion 250mx. The company was founded by Kenneth A. Gall in 2004 and is headquartered in Littleton, MA. | Health Technology |